Emil Mladenov

2.9k total citations
54 papers, 2.3k citations indexed

About

Emil Mladenov is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Emil Mladenov has authored 54 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 23 papers in Oncology and 22 papers in Cancer Research. Recurrent topics in Emil Mladenov's work include DNA Repair Mechanisms (50 papers), Carcinogens and Genotoxicity Assessment (21 papers) and PARP inhibition in cancer therapy (15 papers). Emil Mladenov is often cited by papers focused on DNA Repair Mechanisms (50 papers), Carcinogens and Genotoxicity Assessment (21 papers) and PARP inhibition in cancer therapy (15 papers). Emil Mladenov collaborates with scholars based in Germany, Bulgaria and United States. Emil Mladenov's co-authors include George Iliakis, Aashish Soni, Simon Magin, Boyka Anachkova, Fanghua Li, Thomas Helleday, Sotirios K. Sotiriou, Juha Rantala, Lorenzo Costantino and James E. Haber and has published in prestigious journals such as Science, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Emil Mladenov

54 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emil Mladenov Germany 23 1.8k 644 506 379 312 54 2.3k
Kuniyoshi Iwabuchi Japan 22 2.5k 1.4× 1.1k 1.8× 593 1.2× 158 0.4× 167 0.5× 40 2.9k
Mitsumasa Hashimoto Japan 20 1.5k 0.8× 510 0.8× 395 0.8× 136 0.4× 151 0.5× 60 2.0k
Cordula U. Kirchgessner United States 8 2.1k 1.1× 733 1.1× 575 1.1× 133 0.4× 163 0.5× 8 2.4k
Penelope A. Jeggo United Kingdom 23 3.1k 1.7× 872 1.4× 834 1.6× 216 0.6× 247 0.8× 33 3.6k
Julie M. Bailis United States 21 1.5k 0.8× 788 1.2× 273 0.5× 124 0.3× 147 0.5× 55 2.0k
Jordi Camps Spain 29 1.4k 0.8× 769 1.2× 908 1.8× 276 0.7× 87 0.3× 87 2.6k
M.S. Sasaki Japan 29 1.3k 0.7× 440 0.7× 830 1.6× 407 1.1× 587 1.9× 69 2.4k
Benjamin P. Chen United States 9 1.6k 0.9× 708 1.1× 400 0.8× 187 0.5× 122 0.4× 11 1.9k
Ian R. Radford Australia 22 1.4k 0.7× 425 0.7× 687 1.4× 295 0.8× 485 1.6× 41 1.8k
Joseph M. Amann United States 28 1.8k 1.0× 825 1.3× 426 0.8× 605 1.6× 65 0.2× 53 2.7k

Countries citing papers authored by Emil Mladenov

Since Specialization
Citations

This map shows the geographic impact of Emil Mladenov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emil Mladenov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emil Mladenov more than expected).

Fields of papers citing papers by Emil Mladenov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emil Mladenov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emil Mladenov. The network helps show where Emil Mladenov may publish in the future.

Co-authorship network of co-authors of Emil Mladenov

This figure shows the co-authorship network connecting the top 25 collaborators of Emil Mladenov. A scholar is included among the top collaborators of Emil Mladenov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emil Mladenov. Emil Mladenov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soni, Aashish, Yanjie Sun, Emil Mladenov, et al.. (2024). Talazoparib enhances resection at DSBs and renders HR-proficient cancer cells susceptible to Polθ inhibition. Radiotherapy and Oncology. 200. 110475–110475. 2 indexed citations
2.
Soni, Aashish, Daniela Beißer, Emil Mladenov, et al.. (2024). NGS Detects Extensive Genomic Alterations in Survivors of Irradiated Normal Human Fibroblast Cells. Radiation Research. 203(1). 37–52. 1 indexed citations
3.
Li, Fanghua, Emil Mladenov, Yanjie Sun, et al.. (2023). Low CDK Activity and Enhanced Degradation by APC/CCDH1 Abolishes CtIP Activity and Alt-EJ in Quiescent Cells. Cells. 12(11). 1530–1530. 8 indexed citations
5.
Mladenov, Emil, et al.. (2023). New Facets of DNA Double Strand Break Repair: Radiation Dose as Key Determinant of HR versus c-NHEJ Engagement. International Journal of Molecular Sciences. 24(19). 14956–14956. 20 indexed citations
6.
Xu, Shan, Ali Sak, Michael Groneberg, et al.. (2022). Selective vulnerability of ARID1A deficient colon cancer cells to combined radiation and ATR-inhibitor therapy. Frontiers in Oncology. 12. 999626–999626. 13 indexed citations
7.
Mladenov, Emil, et al.. (2019). Radiation-dose-dependent functional synergisms between ATM, ATR and DNA-PKcs in checkpoint control and resection in G2-phase. Scientific Reports. 9(1). 8255–8255. 58 indexed citations
8.
Mladenov, Emil, et al.. (2019). DNA-PKcs and ATM epistatically suppress DNA end resection and hyperactivation of ATR-dependent G2-checkpoint in S-phase irradiated cells. Scientific Reports. 9(1). 14597–14597. 30 indexed citations
9.
Keul, Petra, Sarah Weske, Markus H. Gräler, et al.. (2019). Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages. Journal of Lipid Research. 60(3). 506–515. 45 indexed citations
10.
Mladenov, Emil, Janapriya Saha, & George Iliakis. (2018). Processing-Challenges Generated by Clusters of DNA Double-Strand Breaks Underpin Increased Effectiveness of High-LET Radiation and Chromothripsis. Advances in experimental medicine and biology. 1044. 149–168. 20 indexed citations
11.
Suntharalingam, Saravanabavaan, Emil Mladenov, Theresia Sarabhai, et al.. (2018). Abdominopelvic 1.5-T and 3.0-T MR Imaging in Healthy Volunteers: Relationship to Formation of DNA Double-Strand Breaks. Radiology. 288(2). 529–535. 7 indexed citations
12.
Mladenov, Emil, et al.. (2016). Novel Biological Approaches for Testing the Contributions of Single DSBs and DSB Clusters to the Biological Effects of High LET Radiation. Frontiers in Oncology. 6. 163–163. 22 indexed citations
13.
Soni, Aashish, et al.. (2016). Chromosome thripsis by DNA double strand break clusters causes enhanced cell lethality, chromosomal translocations and 53BP1-recruitment. Nucleic Acids Research. 44(16). 7673–7690. 49 indexed citations
14.
Singh, Satyendra Kumar, et al.. (2013). Reduced contribution of thermally labile sugar lesions to DNA double strand break formation after exposure to heavy ions. Radiation Oncology. 8(1). 77–77. 19 indexed citations
15.
Singh, Satyendra Kumar, et al.. (2012). Inhibition of B-NHEJ in Plateau-Phase Cells Is Not a Direct Consequence of Suppressed Growth Factor Signaling. International Journal of Radiation Oncology*Biology*Physics. 84(2). e237–e243. 18 indexed citations
16.
Markaki, Yolanda, et al.. (2012). The imprinted NPAP1/C15orf2 gene in the Prader–Willi syndrome region encodes a nuclear pore complex associated protein. Human Molecular Genetics. 21(18). 4038–4048. 22 indexed citations
17.
Iliakis, George, Emil Mladenov, & Nge Cheong. (2012). In Vitro Rejoining of Double Strand Breaks in Genomic DNA. Methods in molecular biology. 471–484. 4 indexed citations
18.
Iliakis, George, et al.. (2012). Analysis of Inhibition of DNA Replication in Irradiated Cells Using the SV40 Based In Vitro Assay of DNA Replication. Methods in molecular biology. 920. 591–602. 1 indexed citations
19.
Mladenov, Emil, Irina R. Tsaneva, & Boyka Anachkova. (2007). Cell Cycle–Dependent Association of Rad51 with the Nuclear Matrix. DNA and Cell Biology. 26(1). 36–43. 9 indexed citations
20.
Mladenov, Emil, Boyka Anachkova, & Irina R. Tsaneva. (2006). Sub‐nuclear localization of Rad51 in response to DNA damage. Genes to Cells. 11(5). 513–524. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026